Startups
VGXI, Inc. is a leading contract manufacturer of cGMP plasmid pharmaceuticals for DNA vaccine and ge
Overview
Location
United States, New Jersey, Monroe Township
Employees
51-200
Phone
+1 936-304-2333
Founded date
1997
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 31, 2023 | VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer | VGXI has long been recognized for its exceptional quality in DNA products and services, and under Mr. Whitmore's leadership, the company aims to fuel rapid growth, consolidate its global brand positioning, and expand its client base. CONROE... |
| Apr 27, 2023 | VGXI, Inc. Names James Smith as New Chief Accounting Officer | We are thrilled to welcome [Jim] to VGXI's leadership team and are confident that his skills and experience will help drive our continued growth and success. CONROE, Texas (PRWEB) April 27, 2023 VGXI Inc., a leading contract development and... |
| Oct 10, 2022 | VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility | This new VGXI headquarters is purpose-built to leverage the company’s existing expertise in DNA and RNA manufacturing and greatly expand our capacity to support growing industry demands. CONROE, Texas (PRWEB) October 10, 2022 VGXI, Inc., a ... |
| Aug 17, 2022 | VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility | The new VGXI headquarters is ready to support our clients as they achieve successful late phase and commercial launch of their products. Combined with our highly skilled and dedicated team, we are confident VGXI will continue to meet the gr... |
| Mar 30, 2022 | VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer's Disease | VGXI is honored to continue supporting IMM and their collaborators with quality GMP plasmid manufacturing services... We look forward to enabling the successful first-in-man clinical trials for IMM’s preventive Alzheimer’s disease vaccine A... |
| Aug 10, 2021 | VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU | Our team has extensive experience producing often challenging gene therapy plasmids, and VGXI is honored to support Rare Trait in the clinical translation of this potentially life-changing therapy. THE WOODLANDS, Texas (PRWEB) August 10, 20... |
| Apr 20, 2021 | VGXI Celebrates Topping Out for New Headquarters and Manufacturing Facility in Conroe, TX | The expanded capacity, flexibility, and specialized capabilities the purpose-built plant will offer our clients perfectly complements our experienced team’s technical skill and commitment to quality. THE WOODLANDS, Texas (PRWEB) April 20, 2... |
| Mar 16, 2021 | VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies | The renewed agreement is a testament to the experience and capabilities of the VGXI team in meeting the challenging requirements of this project. THE WOODLANDS, Texas (PRWEB) March 16, 2021 VGXI, Inc., an industry leading manufacturer for p... |
Reviews 0
FAQ about VGXI
When was VGXI founded?
VGXI was founded in 1997.
What has the press written about VGXI?
Parsers VC has collected 9 articles mentioning VGXI, among them “VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer” (May 31, 2023) and “VGXI, Inc. Names James Smith as New Chief Accounting Officer” (Apr 27, 2023).
Is VGXI still active?
Yes, VGXI is active; its latest activity on Parsers VC dates from Nov 14, 2023.